Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)
Swatantra Kumar, Vimal K. Maurya, Anil K. Prasad, et al.
VirusDisease (2020) Vol. 31, Iss. 1, pp. 13-21
Open Access | Times Cited: 238

Showing 1-25 of 238 citing articles:

SARS-CoV-2 variants, spike mutations and immune escape
William T. Harvey, Alessandro M. Carabelli, Ben Jackson, et al.
Nature Reviews Microbiology (2021) Vol. 19, Iss. 7, pp. 409-424
Open Access | Times Cited: 3420
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Qianqian Li, Jiajing Wu, Jianhui Nie, et al.
Cell (2020) Vol. 182, Iss. 5, pp. 1284-1294.e9
Open Access | Times Cited: 1553
COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
Abdurrahman Tufan, Aslıhan Avanoğlu Güler, Marco Matucci‐Cerinic
TURKISH JOURNAL OF MEDICAL SCIENCES (2020) Vol. 50, Iss. SI-1, pp. 620-632
Open Access | Times Cited: 481
Molecular representations in AI-driven drug discovery: a review and practical guide
Laurianne David, Amol Thakkar, Rocío Mercado, et al.
Journal of Cheminformatics (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 409
The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2
Shibi Muralidar, Senthil Visaga Ambi, Saravanan Sekaran, et al.
Biochimie (2020) Vol. 179, pp. 85-100
Open Access | Times Cited: 312
Characterization of the novel SARS‐CoV‐2 Omicron (B.1.1.529) variant of concern and its global perspective
Shailendra K. Saxena, Swatantra Kumar, Saniya Ansari, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1738-1744
Closed Access | Times Cited: 292
Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor
Vimal K. Maurya, Swatantra Kumar, Anil K. Prasad, et al.
VirusDisease (2020) Vol. 31, Iss. 2, pp. 179-193
Open Access | Times Cited: 209
Remdesivir for the treatment of COVID-19
Kelly Ansems, Felicitas Grundeis, Karolina Dahms, et al.
Cochrane library (2021) Vol. 2021, Iss. 8
Open Access | Times Cited: 197
Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Swatantra Kumar, Rajni Nyodu, Vimal K. Maurya, et al.
Medical virology (2020), pp. 23-31
Open Access | Times Cited: 192
Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
Ma’mon M. Hatmal, Walhan Alshaer, Mohammad A. I. Al-Hatamleh, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2638-2638
Open Access | Times Cited: 181
The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
Eugenia Quirós-Roldán, Giorgio Biasiotto, Paola Magro, et al.
Pharmacological Research (2020) Vol. 158, pp. 104904-104904
Open Access | Times Cited: 157
Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy
Claudia Alteri, Valeria Cento, Antonio Piralla, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 121
Animal models for COVID-19: advances, gaps and perspectives
Changfa Fan, Yong Wu, Rui Xiong, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 84
The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis
Ying‐Nai Wang, Heng‐Huan Lee, Jennifer L. Hsu, et al.
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 139
Physicochemical properties of SARS‐CoV‐2 for drug targeting, virus inactivation and attenuation, vaccine formulation and quality control
Christin Scheller, Finja Krebs, Robert Minkner, et al.
Electrophoresis (2020) Vol. 41, Iss. 13-14, pp. 1137-1151
Open Access | Times Cited: 127
Convalescent Plasma Therapy for COVID-19: State of the Art
Daniele Focosi, Arthur O. Anderson, Julian W. Tang, et al.
Clinical Microbiology Reviews (2020) Vol. 33, Iss. 4
Open Access | Times Cited: 126
COVID-19 Virulence in Aged Patients Might Be Impacted by the Host Cellular MicroRNAs Abundance/Profile
Sadanand Fulzele, Bikash Sahay, Ibrahim Yusufu, et al.
Aging and Disease (2020) Vol. 11, Iss. 3, pp. 509-509
Open Access | Times Cited: 123
COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development
M Sreepadmanabh, Amit Kumar Sahu, Ajit Chande
Journal of Biosciences (2020) Vol. 45, Iss. 1
Open Access | Times Cited: 110
Recombinant vaccines for COVID-19
Tushar Yadav, Nishant Srivastava, Gourav Mishra, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 12, pp. 2905-2912
Open Access | Times Cited: 103
Discovering small-molecule therapeutics against SARS-CoV-2
Vaibhav Tiwari, Jacob C. Beer, Nehru Viji Sankaranarayanan, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 8, pp. 1535-1544
Open Access | Times Cited: 97
Rehabilitation of patients with COVID-19
Tiantian Sun, Liyun Guo, Fei Tian, et al.
Expert Review of Respiratory Medicine (2020) Vol. 14, Iss. 12, pp. 1249-1256
Closed Access | Times Cited: 96
Antibody detection assays for COVID‐19 diagnosis: an early overview
Sarfaraz Ahmad Ejazi, Sneha Ghosh, Nahid Ali
Immunology and Cell Biology (2020) Vol. 99, Iss. 1, pp. 21-33
Open Access | Times Cited: 95
Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider
Juan García‐Revilla, Tomas Deierborg, José L. Venero, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 88
Host Immune Response and Immunobiology of Human SARS-CoV-2 Infection
Swatantra Kumar, Rajni Nyodu, Vimal K. Maurya, et al.
Medical virology (2020), pp. 43-53
Open Access | Times Cited: 84
Drug targets for COVID-19 therapeutics: Ongoing global efforts
Ambrish Saxena
Journal of Biosciences (2020) Vol. 45, Iss. 1
Open Access | Times Cited: 80
Page 1 - Next Page

Scroll to top